25.03.2014 12:38:00
|
AcelRx Pharma Names Timothy Morris CFO - Quick Facts
(RTTNews) - AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company, Tuesday announced the appointment of Timothy Morris as chief financial officer.
Morris brings 30 years of professional finance and accounting experience to AcelRx, 18 of which were spent in the role of chief financial officer. He was most recently the finance chief of VIVUS, Inc. (VVUS), a commercial-stage biopharmaceutical company.
Morris will be responsible for managing the company's finance operations, its information systems and human resource and investor relations functions. Jim Welch, who had served as CFO since October 2010, departed the company to pursue other business opportunities.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vivus Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |